The Department of Oncology at the Veterinary Specialty Center of the Hudson Valley is looking for canine and feline patients with external non-resectable cancers to participate in a clinical trial with our Telomerase Cancer Vaccine.
An external, superficial tumor would be biopsied here at VSCHV pre vaccine immunotherapy and also at the completion of the vaccine series (5 treatments– 2 weeks apart) also administered here.
We are evaluating the T cell infiltration into the tumor and telomerase antibody response. Patient will receive vaccine at N/C but additional fees for administration apply and will be discussed and clearly presented to any interested client.
For more information, please call 845-632-3200.